GAL and laryngeal carcinoma: The studies showed that GAL prevents proliferation, invasion, and migration of human laryngeal cancer by suppressing PI3K/AKT and p38, resulting in caspase activation, NF-κB dephosphorylation, and mTOR inactivation with decreased Ki-67 expression and increased TUNEL levels [108].